ABBV-744 as a potential therapeutic option for aggressive cancers Secrets
Interventional studies in many cases are future and so are especially tailor-made to evaluate immediate impacts of treatment or preventive actions on condition.- "Our study revealed the crucial function of the KLF16/MYC regulatory axis in modulating tumor growth and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors,